Search by Drug Name or NDC
NDC 63323-0623-75 Sodium chloride 9 mg/mL Details
Sodium chloride 9 mg/mL
Sodium chloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is SODIUM CHLORIDE.
Product Information
| NDC | 63323-0623 |
|---|---|
| Product ID | 63323-623_15b78fed-793b-4320-8c3f-f0df0d9f4cda |
| Associated GPIs | 79750010002021 |
| GCN Sequence Number | 001210 |
| GCN Sequence Number Description | 0.9 % sodium chloride IV SOLN 0.9 % INTRAVEN |
| HIC3 | C1B |
| HIC3 Description | SODIUM/SALINE PREPARATIONS |
| GCN | 02962 |
| HICL Sequence Number | 008255 |
| HICL Sequence Number Description | 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Sodium chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SODIUM CHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 9 |
| Active Ingredient Units | mg/mL |
| Substance Name | SODIUM CHLORIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207310 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0623-75 (63323062375)
| NDC Package Code | 63323-623-75 |
|---|---|
| Billing NDC | 63323062375 |
| Package | 500 mL in 1 BAG (63323-623-75) |
| Marketing Start Date | 2017-09-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |